Inflammation and Anti-Inflammatory Drugs Flashcards
(19 cards)
Late phase local changes in inflammation
Cytokines produced by activated neutrophils and cytokines contribute to degradation of damaged tissue and preparation of injured site for healing
These WBCs release mediators like reactive oxygen species or proteins like TNFα or Hydrolytic alpha
Systemic action of cytokines in response to inflammation
Site of infection has WBCs which release cytokines into body: IL-1, TNFα and IL-6
Once in circulation, they can go into hypothalamus (HT) and produce prostaglandins which raise body temperature to kill microbes
HT also releases ACTH (hormone) which acts on adrenal cortex to produce corticosteroids that act on the liver (in addition to other cytokines) to make it produce acute-phase proteins like C-reactive protein
Cytokines stimulate bone marrow to increase leukocytosis
Describe changes 1 day after colorectal and cardiac surgery
In platelets, neutrophils, lymphocytes, monocytes
Reduction in platelets
Increase in neutrophils
Reduction in Lymphocytes
Increase in Monocytes
Tissue regeneration methods that occur after inflammation
Angiogenesis - Formation of new blood vessels
Fibroblast Proliferation - Most common cell type in connective tissue
Collagen Synthesis
Granulation of Tissue
Caused by dense population of macrophages, fibroblasts and neovascularisation in a loose matrix of collagen after inflammation
Characterised by:
- fibroblast production of collagen
- Proliferation of blood vessels to ensure nutrient/O2 supply
- Metalloporteinases stimulate cell movement in wound area
Which type of hormones affect granulation
Sex hormones
What happens if there is a failure to stop proliferative phase (post inflammation)
Granulomatous conditions; e.g. rheumatoid arthritis or scleroderma
- Cartilage calcification/ossification
Loss of function and pain
These 3 drugs treat such conditions:
Methotrexate (may inhibit angiogenesis)
Etanercept & Adalimumab (Monoclonal antibodies)
(adalimumab gives the drug company the most revenue of all drugs)
Differences in cutaneous wound healing between sexes
Venous ulceration (which is more common in the elderly) in is more common in men and post-menopausal women (thought to be lack of oestrogen)
Prolonged Cutaneous healing is attributed to:
- Prolonged inflammatory response
- Increased protease activity
- Reduced matrix heealing
Experimental observations in mice of sex hormones on wound healing
Basically:
Testosterone prolongs wound healing
Overiectomy gives enhanced inflammation which is reversed by oestrogen and reduces inflammatory response
What was the effect of vaginal oestrogen application for 6 weeks preoperatively
Increased synthesis of various factors that lead to improved outcome in terms of surgical repair
Maturation phase (post inflammatory)
From 21 days to two years
Reduction in cell proliferation at site of inflammation and remodelling (macrophage involved)
Closure of wound is not end point:
Reduction in vascularisation as less nutrients are needed (since metabolic activity declines)
Remodelling of collagen and reinnervation by nerves to increase strength of tissues after return of sensation (lack of elastin causes scar tissue)
Phosphalipase A
Enzyme that converts phosphatidylcholine into arachidonic acid which is then libterated into the extracellular space
Upregulated by inflammatory mediators
How can arachidonic acid be metabolised
By two major sets of enzymes:
- Cyclo-oxygenase
- Lipoxygenase (into leukotrienes)
Forms of COX enzymes
COX-1 (Physiological); functions for stuff like mucosal protection, renal blood flow and haemostasis
COX-2 (Inducible); functions for stuff like inflammation, pain and fever
How does asprin affect COX
Non-competitive inhibitor of cyclooxygenase
Competitive inhibitors of COX
Indomethacin and other NSAIDS
Examples of NSAIDS (also what is abbreviation)
Non-steroidal anti-inflammatory drugs
Ibuprofen
Piroxicam
Diclofenac
Inhibit synthesis of prostaglandins by preventing the metabolism of arachadonic acid through COX-2 inhibition which reduces inflammatory response;
They tend to be applied topically as they can inhibit prostaglandin functions that protect stomach mucosa
What drug changes were made to reduce the side effects of COX-2 inhibitors and NSAIDS; what happened afterwards
Production of selective COX-2 inhibitors that do not target COX-1
Initial results were promising as the drugs had much more selectivity for the inflammtory mediator COX-2 as opposed to COX-1 (physiological).
Turned out to have bad side effects though as COX-2 has beneficial effects on the heart and other things like affecting ovulation
Glucocorticoids
SHort-term steroids that enhance inflammatory response; in the long term they inhibit inflammation though by reducing:
- mediator production with action at the level of phospholipase A2 and COX-2
- Expression of cell adhesion molecules
- Chemotaxis of neutrophils
- Cytokine production